We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Catch up on all the biggest pharma news to hit the industry last month, spanning from new acquisitions, insights on the NHS ...
The Cloud Development Kit (CDK) is an open source framework, developed by AWS, that allows developers to define cloud application infrastructure as code using programming languages such as Python, ...
Cybersecurity researchers have disclosed a security flaw impacting Amazon Web Services (AWS) Cloud Development Kit (CDK) that could have resulted in an account takeover under specific circumstances.
UCB will advance its anti-tau antibody for Alzheimer’s disease solo after Roche and Genentech walked away from the asset known as bepranemab.
UCB granted Roche and its biotech unit Genentech an exclusive worldwide license to bepranemab, then called UCB0107, in 2020 as part of a deal worth around $2 billion in milestones. The agreement ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. I am so ...
--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline one-year results from the open-label, single-arm Phase IV ELEVATUM study ...
As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential ...
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning! For those who ...
Lonza (ticker LONN. S) completed its $1.2 billion purchase of Genentech’s Vacaville campus, considered home of the world’s largest biopharmaceutical manufacturing site, the Swiss drugmaker ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), presented positive 2-year data from the ongoing RAINBOWFISH study at the 29th ...